_id

6915fa9fbc934aba376b26d4

Ticker

SLXNW

Name

Biomotion Sciences Warrant

Exchange

NASDAQ

Address

The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001

Country

USA

Sector

Industry

Currency

USD

Website

https://silexion.com

Description

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Last Close

0.032

Volume

748

Current Price

0.037

Change

-0.0095

Last Updated

2026-01-07T11:57:00.957Z

Image

data:image/webp;base64,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

Ipo Date

2024-08-16T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

4000

Gross Profit

-4000

Operating Expenses

3288000

Operating Income

-3292000

Interest Expense

4000

Pretax Income

-3262000

Net Income

-3262000

Eps

-2.879951406338012

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-

EBITDA

-3258000

Operating Margin

-

Total Other Income Expense Net

30000

Cash

9243000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

11055000

Property Plant Equipment

468000

Total Assets

11614000

Payables

946000

Short Term Debt

174000

Long Term Debt

1540000

Total Liabilities

4637000

Equity

6977000

Bs_currency_symbol

USD

Depreciation

4000

Change In Working Capital

393000

Cash From Operations

-2843000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

8624000

Net Change In Cash

5778000

Cf_currency_symbol

USD

PE

-

PB

0.006006642683101619

ROE

-46.753619033968754

ROA

-28.086791802996387

FCF

-2843000

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

4

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.3

Garp Investing Score

1.5

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

0.5

Quality Investing Score

2

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

4000

Quarters > 0 > income Statement > gross Profit

-4000

Quarters > 0 > income Statement > operating Expenses

3288000

Quarters > 0 > income Statement > operating Income

-3292000

Quarters > 0 > income Statement > interest Expense

4000

Quarters > 0 > income Statement > pretax Income

-3262000

Quarters > 0 > income Statement > net Income

-3262000

Quarters > 0 > income Statement > eps

-2.879951406338012

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

1132658

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-3258000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

30000

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

9243000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

11055000

Quarters > 0 > balance Sheet > property Plant Equipment

468000

Quarters > 0 > balance Sheet > total Assets

11614000

Quarters > 0 > balance Sheet > payables

946000

Quarters > 0 > balance Sheet > short Term Debt

174000

Quarters > 0 > balance Sheet > long Term Debt

1540000

Quarters > 0 > balance Sheet > total Liabilities

4637000

Quarters > 0 > balance Sheet > equity

6977000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-3262000

Quarters > 0 > cash Flow > depreciation

4000

Quarters > 0 > cash Flow > change In Working Capital

393000

Quarters > 0 > cash Flow > cash From Operations

-2843000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

8624000

Quarters > 0 > cash Flow > net Change In Cash

5778000

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-2.879951406338012

Quarters > 0 > ratios > PB

0.006006642683101619

Quarters > 0 > ratios > ROE

-46.753619033968754

Quarters > 0 > ratios > ROA

-28.086791802996387

Quarters > 0 > ratios > FCF

-2843000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

3000

Quarters > 1 > income Statement > gross Profit

-3000

Quarters > 1 > income Statement > operating Expenses

2284000

Quarters > 1 > income Statement > operating Income

-2284000

Quarters > 1 > income Statement > interest Expense

0

Quarters > 1 > income Statement > pretax Income

-2500000

Quarters > 1 > income Statement > net Income

-2503000

Quarters > 1 > income Statement > eps

-4.319091662065158

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

579520

Quarters > 1 > income Statement > income Tax Expense

3000

Quarters > 1 > income Statement > EBITDA

-2497000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-216000

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

3466000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

5237000

Quarters > 1 > balance Sheet > property Plant Equipment

502000

Quarters > 1 > balance Sheet > total Assets

5797000

Quarters > 1 > balance Sheet > payables

692000

Quarters > 1 > balance Sheet > short Term Debt

171000

Quarters > 1 > balance Sheet > long Term Debt

3190000

Quarters > 1 > balance Sheet > total Liabilities

5677000

Quarters > 1 > balance Sheet > equity

120000

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-2503000

Quarters > 1 > cash Flow > depreciation

3000

Quarters > 1 > cash Flow > change In Working Capital

-273000

Quarters > 1 > cash Flow > cash From Operations

-2507000

Quarters > 1 > cash Flow > capital Expenditures

1000

Quarters > 1 > cash Flow > cash From Investing

-1000

Quarters > 1 > cash Flow > cash From Financing

-195000

Quarters > 1 > cash Flow > net Change In Cash

-2689000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-4.319091662065158

Quarters > 1 > ratios > PB

0.17868533333333333

Quarters > 1 > ratios > ROE

-2085.8333333333335

Quarters > 1 > ratios > ROA

-43.17750560634811

Quarters > 1 > ratios > FCF

-2508000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

23

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

4000

Quarters > 2 > income Statement > gross Profit

-4000

Quarters > 2 > income Statement > operating Expenses

1650000

Quarters > 2 > income Statement > operating Income

-1650000

Quarters > 2 > income Statement > interest Expense

9000

Quarters > 2 > income Statement > pretax Income

-1735000

Quarters > 2 > income Statement > net Income

-1735000

Quarters > 2 > income Statement > eps

-0.25593745390175543

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

6779000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-1722000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-85000

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

6152000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

7722000

Quarters > 2 > balance Sheet > property Plant Equipment

534000

Quarters > 2 > balance Sheet > total Assets

8308000

Quarters > 2 > balance Sheet > payables

722000

Quarters > 2 > balance Sheet > short Term Debt

155000

Quarters > 2 > balance Sheet > long Term Debt

2993000

Quarters > 2 > balance Sheet > total Liabilities

5722000

Quarters > 2 > balance Sheet > equity

2586000

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-1735000

Quarters > 2 > cash Flow > depreciation

4000

Quarters > 2 > cash Flow > change In Working Capital

-824000

Quarters > 2 > cash Flow > cash From Operations

-2453000

Quarters > 2 > cash Flow > capital Expenditures

6000

Quarters > 2 > cash Flow > cash From Investing

-6000

Quarters > 2 > cash Flow > cash From Financing

7432000

Quarters > 2 > cash Flow > net Change In Cash

4963000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.25593745390175543

Quarters > 2 > ratios > PB

0.09699265274555298

Quarters > 2 > ratios > ROE

-67.09203402938901

Quarters > 2 > ratios > ROA

-20.88348579682234

Quarters > 2 > ratios > FCF

-2459000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

27

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

1900000

Quarters > 3 > income Statement > operating Income

-1900000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-1746000

Quarters > 3 > income Statement > net Income

-1747000

Quarters > 3 > income Statement > eps

-0.944835045970795

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

1849000

Quarters > 3 > income Statement > income Tax Expense

1000

Quarters > 3 > income Statement > EBITDA

-5843000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

154000

Quarters > 3 > income Statement > currency_symbol

USD

Quarters > 3 > balance Sheet > cash

1222000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

2250000

Quarters > 3 > balance Sheet > property Plant Equipment

560000

Quarters > 3 > balance Sheet > total Assets

2863000

Quarters > 3 > balance Sheet > payables

929000

Quarters > 3 > balance Sheet > short Term Debt

1162000

Quarters > 3 > balance Sheet > long Term Debt

2961000

Quarters > 3 > balance Sheet > total Liabilities

6852000

Quarters > 3 > balance Sheet > equity

-3989000

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-1747000

Quarters > 3 > cash Flow > depreciation

-12000

Quarters > 3 > cash Flow > change In Working Capital

-947000

Quarters > 3 > cash Flow > cash From Operations

-2926000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

2184000

Quarters > 3 > cash Flow > net Change In Cash

-753000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.944835045970795

Quarters > 3 > ratios > PB

-0.017150413637503133

Quarters > 3 > ratios > ROE

43.79543745299574

Quarters > 3 > ratios > ROA

-61.019909186168356

Quarters > 3 > ratios > FCF

-2926000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

38

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

0

Annuals > 0 > income Statement > cost Of Revenue

25000

Annuals > 0 > income Statement > gross Profit

-25000

Annuals > 0 > income Statement > operating Expenses

12546000

Annuals > 0 > income Statement > operating Income

-12571000

Annuals > 0 > income Statement > interest Expense

52000

Annuals > 0 > income Statement > pretax Income

-16509000

Annuals > 0 > income Statement > net Income

-16443000

Annuals > 0 > income Statement > eps

-26.357466426008983

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

623846

Annuals > 0 > income Statement > income Tax Expense

10000

Annuals > 0 > income Statement > EBITDA

-16432000

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

-3938000

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

1187000

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

-

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

2250000

Annuals > 0 > balance Sheet > property Plant Equipment

560000

Annuals > 0 > balance Sheet > total Assets

2863000

Annuals > 0 > balance Sheet > payables

929000

Annuals > 0 > balance Sheet > short Term Debt

1162000

Annuals > 0 > balance Sheet > long Term Debt

2961000

Annuals > 0 > balance Sheet > total Liabilities

6852000

Annuals > 0 > balance Sheet > equity

-3989000

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-16519000

Annuals > 0 > cash Flow > depreciation

25000

Annuals > 0 > cash Flow > change In Working Capital

-1580000

Annuals > 0 > cash Flow > cash From Operations

-8396000

Annuals > 0 > cash Flow > capital Expenditures

22000

Annuals > 0 > cash Flow > cash From Investing

-22000

Annuals > 0 > cash Flow > cash From Financing

5104000

Annuals > 0 > cash Flow > net Change In Cash

-3375000

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-26.357466426008983

Annuals > 0 > ratios > PB

-0.0046917473050889945

Annuals > 0 > ratios > ROE

412.2085735773377

Annuals > 0 > ratios > ROA

-574.3276283618582

Annuals > 0 > ratios > FCF

-8418000

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

31

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

-

Annuals > 1 > income Statement > gross Profit

-

Annuals > 1 > income Statement > operating Expenses

4681000

Annuals > 1 > income Statement > operating Income

-4681000

Annuals > 1 > income Statement > interest Expense

9000

Annuals > 1 > income Statement > pretax Income

-5076000

Annuals > 1 > income Statement > net Income

-4942000

Annuals > 1 > income Statement > eps

-7.255973477963394

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

681094

Annuals > 1 > income Statement > income Tax Expense

32000

Annuals > 1 > income Statement > EBITDA

-4636000

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

-395000

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

4595000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

-

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

4979000

Annuals > 1 > balance Sheet > property Plant Equipment

247000

Annuals > 1 > balance Sheet > total Assets

5256000

Annuals > 1 > balance Sheet > payables

319000

Annuals > 1 > balance Sheet > short Term Debt

112000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

17312000

Annuals > 1 > balance Sheet > equity

-15476000

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-5108000

Annuals > 1 > cash Flow > depreciation

45000

Annuals > 1 > cash Flow > change In Working Capital

87000

Annuals > 1 > cash Flow > cash From Operations

-4529000

Annuals > 1 > cash Flow > capital Expenditures

12000

Annuals > 1 > cash Flow > cash From Investing

573000

Annuals > 1 > cash Flow > cash From Financing

522000

Annuals > 1 > cash Flow > net Change In Cash

-3664000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-7.255973477963394

Annuals > 1 > ratios > PB

-0.0013202907728095113

Annuals > 1 > ratios > ROE

31.933316102352027

Annuals > 1 > ratios > ROA

-94.02587519025876

Annuals > 1 > ratios > FCF

-4541000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

30

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

0

Annuals > 2 > income Statement > cost Of Revenue

-

Annuals > 2 > income Statement > gross Profit

-

Annuals > 2 > income Statement > operating Expenses

1232342

Annuals > 2 > income Statement > operating Income

-1232342

Annuals > 2 > income Statement > interest Expense

85000

Annuals > 2 > income Statement > pretax Income

584025

Annuals > 2 > income Statement > net Income

584025

Annuals > 2 > income Statement > eps

0.3490884638374178

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

1673000

Annuals > 2 > income Statement > income Tax Expense

24000

Annuals > 2 > income Statement > EBITDA

584025

Annuals > 2 > income Statement > operating Margin

-

Annuals > 2 > income Statement > total Other Income Expense Net

1816367

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

8259000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

-

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

8839000

Annuals > 2 > balance Sheet > property Plant Equipment

464000

Annuals > 2 > balance Sheet > total Assets

9333000

Annuals > 2 > balance Sheet > payables

240000

Annuals > 2 > balance Sheet > short Term Debt

115000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

16412000

Annuals > 2 > balance Sheet > equity

-10665000

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-3488000

Annuals > 2 > cash Flow > depreciation

57000

Annuals > 2 > cash Flow > change In Working Capital

239000

Annuals > 2 > cash Flow > cash From Operations

-3335000

Annuals > 2 > cash Flow > capital Expenditures

40000

Annuals > 2 > cash Flow > cash From Investing

-524000

Annuals > 2 > cash Flow > cash From Financing

2752000

Annuals > 2 > cash Flow > net Change In Cash

-1774000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

0.3490884638374178

Annuals > 2 > ratios > PB

-0.0047060478199718704

Annuals > 2 > ratios > ROE

-5.476090014064697

Annuals > 2 > ratios > ROA

6.257634201221472

Annuals > 2 > ratios > FCF

-3375000

Annuals > 2 > ratios > Piotroski FScore

1

Annuals > 2 > ratios > fcf Percent

-

Annuals > 2 > health Score

35

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

-

Annuals > 3 > income Statement > cost Of Revenue

-

Annuals > 3 > income Statement > gross Profit

-

Annuals > 3 > income Statement > operating Expenses

943933

Annuals > 3 > income Statement > operating Income

-943933

Annuals > 3 > income Statement > interest Expense

-

Annuals > 3 > income Statement > pretax Income

-755218

Annuals > 3 > income Statement > net Income

-755218

Annuals > 3 > income Statement > eps

-0.4574306480920654

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

1651000

Annuals > 3 > income Statement > income Tax Expense

-

Annuals > 3 > income Statement > EBITDA

-755218

Annuals > 3 > income Statement > operating Margin

-

Annuals > 3 > income Statement > total Other Income Expense Net

188715

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

38944

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

-

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

407797

Annuals > 3 > balance Sheet > property Plant Equipment

-

Annuals > 3 > balance Sheet > total Assets

115414169

Annuals > 3 > balance Sheet > payables

-

Annuals > 3 > balance Sheet > short Term Debt

-

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

508916

Annuals > 3 > balance Sheet > equity

114905252

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

-755218

Annuals > 3 > cash Flow > depreciation

188715

Annuals > 3 > cash Flow > change In Working Capital

-469675

Annuals > 3 > cash Flow > cash From Operations

-1407236

Annuals > 3 > cash Flow > capital Expenditures

4

Annuals > 3 > cash Flow > cash From Investing

-

Annuals > 3 > cash Flow > cash From Financing

116400851

Annuals > 3 > cash Flow > net Change In Cash

-12757

Annuals > 3 > cash Flow > currency_symbol

-

Annuals > 3 > ratios > PE

-0.4574306480920654

Annuals > 3 > ratios > PB

0.00043105079304817155

Annuals > 3 > ratios > ROE

-0.6572528120820796

Annuals > 3 > ratios > ROA

-0.6543546659336082

Annuals > 3 > ratios > FCF

-1407240

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-

Annuals > 3 > health Score

41

Valuation > metrics > PE

-2.879951406338012

Valuation > metrics > PB

0.006006642683101619

Valuation > final Score

70

Valuation > verdict

99.4% Undervalued

Profitability > metrics > ROE

-46.753619033968754

Profitability > metrics > ROA

-29.507010402532792

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.6646122975490899

Risk > metrics > Interest Coverage

-823

Risk > final Score

-3244

Risk > verdict

High

Liquidity > metrics > Current Ratio

9.870535714285714

Liquidity > metrics > Quick Ratio

9.870535714285714

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

50

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

55

Prev Risks > 0

-3039

Prev Risks > 1

-715

Prev Risks > 2

28

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

77

Updated At

2026-01-20T22:35:18.020Z